Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.